These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 14640376)

  • 21. Prestimulation parameters predicting live birth in anovulatory WHO Group II patients undergoing ovulation induction with gonadotrophins.
    Nyboe Andersen A; Balen AH; Platteau P; Pettersson G; Arce JC
    Hum Reprod; 2010 Aug; 25(8):1988-95. PubMed ID: 20522443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gonadotrophin induction of ovulation using a step-down dose regimen: single-centre clinical experience in 82 patients.
    van Santbrink EJ; Donderwinkel PF; van Dessel TJ; Fauser BC
    Hum Reprod; 1995 May; 10(5):1048-53. PubMed ID: 7657739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction.
    Westergaard LG; Laursen SB; Andersen CY
    Hum Reprod; 2000 May; 15(5):1003-8. PubMed ID: 10783342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cumulative success of ovulation induction therapy with gonadotrophins in therapy-naïve anovulatory women: An observational study.
    Pontré J; Langdon F; Murray K; Livingston J; Hart R
    Aust N Z J Obstet Gynaecol; 2020 Apr; 60(2):271-277. PubMed ID: 31994179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of anovulatory infertility.
    Li RH; Ng EH
    Best Pract Res Clin Obstet Gynaecol; 2012 Dec; 26(6):757-68. PubMed ID: 22703626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Follicle-stimulating hormone receptor polymorphism affects the outcome of ovulation induction in normogonadotropic (World Health Organization class 2) anovulatory subfertility.
    Valkenburg O; van Santbrink EJ; König TE; Themmen AP; Uitterlinden AG; Fauser BC; Lambalk CB; Laven JS
    Fertil Steril; 2015 Apr; 103(4):1081-1088.e3. PubMed ID: 25721191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors related to successful ovulation induction in patients with WHO group II anovulatory infertility.
    Howles CM; Alam V; Tredway D; Homburg R; Warne DW
    Reprod Biomed Online; 2010 Feb; 20(2):182-90. PubMed ID: 20113956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovulation induction in clomiphene-resistant anovulatory women: differential follicular response to purified urinary follicle-stimulating hormone (FSH) versus purified urinary FSH and luteinizing hormone.
    Hoffman DI; Lobo RA; Campeau JD; Tsai HM; Holmberg EA; Ono T; Frederick JJ; Platt LD; diZerega GS
    J Clin Endocrinol Metab; 1985 May; 60(5):922-7. PubMed ID: 3920235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cumulative conception and live birth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction in 200 patients.
    Balen AH; Braat DD; West C; Patel A; Jacobs HS
    Hum Reprod; 1994 Aug; 9(8):1563-70. PubMed ID: 7989523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial.
    Youssef MA; van Wely M; Al-Inany H; Madani T; Jahangiri N; Khodabakhshi S; Alhalabi M; Akhondi M; Ansaripour S; Tokhmechy R; Zarandi L; Rizk A; El-Mohamedy M; Shaeer E; Khattab M; Mochtar MH; van der Veen F
    Hum Reprod; 2017 Jan; 32(1):112-118. PubMed ID: 27836979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
    Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
    Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination.
    Palomba S; Falbo A; Orio F; Manguso F; Russo T; Tolino A; Annamaria C; Dale B; Zullo F
    Hum Reprod; 2005 Oct; 20(10):2879-86. PubMed ID: 15958399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant FSH in alternative doses or versus urinary gonadotrophins for ovulation induction in subfertility associated with polycystic ovary syndrome: a systematic review based on a Cochrane review.
    van Wely M; Bayram N; van der Veen F
    Hum Reprod; 2003 Jun; 18(6):1143-9. PubMed ID: 12773438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovulation triggers in anovulatory women undergoing ovulation induction.
    George K; Nair R; Tharyan P
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006900. PubMed ID: 18646175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ovulation induction with pure FSH in anovulatory patients resistant to clomifene citrate].
    Kably-Ambe A; Reyes-Cuervo H; Barrón-Vallejo J
    Ginecol Obstet Mex; 1996 Jul; 64():293-6. PubMed ID: 8756188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovulation induction and controlled ovarian stimulation using letrozole gonadotropin combination: A single center retrospective cohort study.
    Arya S; Kupesic-Plavsic S; Mulla ZD; Dwivedi AK; Crisp Z; Jose J; Noble LS
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():123-128. PubMed ID: 28985546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laparoscopic "drilling" by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome.
    Farquhar C; Vandekerckhove P; Arnot M; Lilford R
    Cochrane Database Syst Rev; 2000; (2):CD001122. PubMed ID: 10796746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles.
    Van Wely M; Westergaard LG; Bossuyt PM; Van der Veen F
    Cochrane Database Syst Rev; 2003; (1):CD003973. PubMed ID: 12535497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An effective alternative to only gonadotrophin for controlled ovarian stimulation in unexplained infertility patients undergoing intra-uterine insemination: a clinical trial.
    Chaudhury K; Chaudhury S; Khastgir G; Purakaystha S
    J Indian Med Assoc; 2013 Sep; 111(9):589-92, 594. PubMed ID: 24968520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.